Luffa cylindrica suppresses development of Dermatophagoides farinae-induced atopic dermatitis-like skin lesions in Nc/Nga mice
暂无分享,去创建一个
[1] W. Carr. Topical Calcineurin Inhibitors for Atopic Dermatitis: Review and Treatment Recommendations , 2013, Pediatric Drugs.
[2] T. Kao,et al. Functional components in Luffa cylindrica and their effects on anti-inflammation of macrophage cells. , 2012, Food chemistry.
[3] J. Ring,et al. Guidelines for treatment of atopic eczema (atopic dermatitis) Part II , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.
[4] J. Ring,et al. Guidelines for treatment of atopic eczema (atopic dermatitis) Part I , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.
[5] H. Ha,et al. Angelicae Dahuricae Radix Inhibits Dust Mite Extract-Induced Atopic Dermatitis-Like Skin Lesions in NC/Nga Mice , 2012, Evidence-based complementary and alternative medicine : eCAM.
[6] T. Kosaka,et al. Prior or coinstantaneous oral exposure to environmental immunosuppressive agents aggravates mite allergen-induced atopic dermatitis-like immunoreaction in NC/Nga mice. , 2011, Toxicology.
[7] P. Shaw,et al. Structural characterization and anti-HIV-1 activities of arginine/glutamate-rich polypeptide Luffin P1 from the seeds of sponge gourd (Luffa cylindrica). , 2011, Journal of structural biology.
[8] Fu-Tong Liu,et al. IgE, Mast Cells, and Eosinophils in Atopic Dermatitis , 2011, Clinical reviews in allergy & immunology.
[9] F. He,et al. Cloning and soluble expression of mature alpha-luffin from Luffa cylindrica and its antitumor activities in vitro. , 2010, Acta biochimica et biophysica Sinica.
[10] T. Terui. Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: overview of the pathophysiology of atopic dermatitis. , 2009, Journal of pharmacological sciences.
[11] A. Gupta,et al. Immunomodulatory effects of two sapogenins 1 and 2 isolated from Luffa cylindrica in Balb/C mice. , 2007, Bioorganic & medicinal chemistry letters.
[12] Giampiero Girolomoni,et al. The contribution of keratinocytes to the pathogenesis of atopic dermatitis. , 2006, European journal of dermatology : EJD.
[13] C. Duez,et al. Dendritic cells and toll-like receptors in allergy and asthma. , 2006, European journal of dermatology : EJD.
[14] H. Williams,et al. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials , 2005, BMJ : British Medical Journal.
[15] D. Margolis,et al. Guidelines of care for atopic dermatitis , 2004 .
[16] T. Luger,et al. The treatment of atopic dermatitis with topical immunomodulators. , 2003, Clinics in dermatology.
[17] M. Boguniewicz,et al. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group. , 1998, The Journal of allergy and clinical immunology.
[18] N. Ishii,et al. Predominance of type 2 cytokine-producing CD4+ and CD8+ cells in patients with atopic dermatitis. , 1997, The Journal of allergy and clinical immunology.
[19] H. Tagami,et al. Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment , 1995, The British journal of dermatology.
[20] D. Leung,et al. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. , 1995, The Journal of allergy and clinical immunology.
[21] M. Tabata,et al. Anti-Allergic Effect of Bryonolic Acid from Luffa cylindrica Cell Suspension Cultures , 1991, Planta medica.
[22] J. Hornung,et al. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line , 1988, The Journal of cell biology.